Corbus Pharmaceuticals Holdings, Inc. entered into a two-year employment agreement with Leonardo Viana Nicacio, MD, effective August 3, 2026, for the position of Chief Medical Officer. The agreement includes an annual base salary of $545,000, a target annual bonus of up to 40% of base salary, and $2,100,000 in equity awards consisting of approximately 75% stock options and 25% restricted stock units. Corbus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing medicines for rare diseases.